Literature DB >> 19161086

Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.

R Imani1, A Karimi, R Rouzbahani, A Rouzbahani.   

Abstract

This study was conducted in 2004 to evaluate the prevalence of hepatitis B (HBV), hepatitis C (HBC) and human immunodeficiency (HIV) virus infection in 133 injecting drug users (IDUs) attending a voluntary rehabilitation centre in Shahr-e-Kord, and to identify risk factors for these infections in this group. Serum samples were screened for HBV, HCV and HIV infection. Only 1 participant (0.8%) was HIV positive, 15 (11.2%) were HCV positive and 8 (6.0%) were positive for HBV surface antigen. There was significant correlation between using shared syringes and infection with HIV, HCV and HBV.

Entities:  

Mesh:

Year:  2008        PMID: 19161086

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  17 in total

Review 1.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

Review 4.  High hepatitis C virus prevalence among drug users in Iran: systematic review and meta-analysis of epidemiological evidence (2001-2012).

Authors:  Mohsen Malekinejad; Soodabeh Navadeh; Ali Lotfizadeh; Afarin Rahimi-Movaghar; Masoumeh Amin-Esmaeili; Alireza Noroozi
Journal:  Int J Infect Dis       Date:  2015-10-13       Impact factor: 3.623

5.  Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors.

Authors:  Zary Nokhodian; Marjan Meshkati; Peyman Adibi; Behrooz Ataei; Nazila Kassaian; Majid Yaran; Parisa Shoaei; Razieh Hassannejad
Journal:  Int J Prev Med       Date:  2012-03

6.  The assessment of hepatitis B seroprevalence in persons with intravenous drug use history in the Isfahan province: Community-based study.

Authors:  Mahsa Khodadoostan; Behrooz Ataei; Ahmad Shavakhi; Tahmine Tavakoli; Zary Nokhodian; Majid Yaran
Journal:  J Res Med Sci       Date:  2014-01       Impact factor: 1.852

7.  Selection of Variables that Influence Drug Injection in Prison: Comparison of Methods with Multiple Imputed Data Sets.

Authors:  Saiedeh Haji-Maghsoudi; Ali Akbar Haghdoost; Mohammad Reza Baneshi
Journal:  Addict Health       Date:  2014

Review 8.  Prevalence of Hepatitis B Virus Infection in Isfahan Province.

Authors:  Zary Nokhodian; Peyman Adibi; Behrooz Ataei
Journal:  Int J Prev Med       Date:  2014-12

Review 9.  Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis.

Authors:  Shah Jahan Shayan; Rajab Nazari; Frank Kiwanuka
Journal:  Harm Reduct J       Date:  2021-05-27

Review 10.  HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.

Authors:  Ghina R Mumtaz; Helen A Weiss; Sara L Thomas; Suzanne Riome; Hamidreza Setayesh; Gabriele Riedner; Iris Semini; Oussama Tawil; Francisca Ayodeji Akala; David Wilson; Laith J Abu-Raddad
Journal:  PLoS Med       Date:  2014-06-17       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.